Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

Earnings Preview: What to Expect From Revvity's Report

Valued at a market cap of $11.6 billion, Revvity, Inc. (RVTY) provides health sciences solutions, technologies, and services. The Waltham, Massachusetts-based company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. It is expected to announce its fiscal Q2 earnings for 2025 before the market opens on Monday, Jul. 28.

Ahead of this event, analysts expect this healthcare company to report a profit of $1.14 per share, down 6.6% from $1.22 per share in the year-ago quarter. The company has topped Wall Street’s earnings estimates in each of the last four quarters. In Q1, Revvity’s EPS of $1.01 outpaced the forecasted figure by 5.2%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.